Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Dairy heavyweight Bel Group is exploring precision fermentation as a strategy to reshape dairy production and meet evolving ...
CHANDIGARH: Executive Director of the North American Punjabi Association (NAPA) Satnam Singh Chahal has strongly demanded ...
MedPage Today on MSN
First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer
BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
Mary Roach encouraged the use of humor to break down barriers in medical discourse while promoting her new book “Replaceable ...
Every year, MIT Technology Review puts out a list of people under 35 who are doing really cool stuff with technology. It’s called the 35 Innovators Under 35, and it’s a big deal. These are the folks ...
Plants are consummate chemists, using the sun's energy and carbon dioxide from the air, to conjure a dazzling array of ...
The Summer Research Showcase featured work that ranged from advancing cancer treatments to improving health care access. More ...
Oct 1 (Reuters) - Biotechnology firm Galapagos' (GLPG.AS), opens new tab board has received non-binding offers from several groups, mainly comprised of financial investors, for its cell therapy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果